← Leaderboards
Lynn Pulliam
Veterans Affairs Med Ctr San Francisco
$14,991,892
Attributed
$15,412,065
Total exposure
13
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,412,065 · 11
VA$0 · 2
By mechanism
R01$13,540,020 · 7
R21$1,872,045 · 4
I01$0 · 1
IS1$0 · 1
Top collaborators
- Judith M Ford4 shared
- Limin Liu1 shared
Most similar at Veterans Affairs Med Ctr San Francisco
Same institution · by research overlap
- Judith M Ford$10,389,985
Others in their field
Top investigators on “Brain”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Michael W Weiner · Northern California Institute Res &Educ$149,959,854
- David A Bennett · Rush University Medical Center$148,375,056
- David Heimbrook · Leidos Biomedical Research, Inc.$145,442,397
- Walter John Curran · Thomas Jefferson University$114,442,832
- Hongkui Zeng · Allen Institute$113,960,965
Research focus
BrainChronicHiv InfectionsCellsImpaired CognitionProteinsPeripheralMonocyteNeuronsResponseMacrophageInflammationPlasmaGenesCognitionCytokineImmuneCognitiveAffectNeurocognitivePathologicFunctional DisorderBiological MarkersNeurologic
Grant awards (45)
Neural and cognitive consequences of COVID-19 survival.$0
I01 · FY2025 · VA
Plasma neuronal-derived exosomes are biomarkers of HIV cognitive impairment$559,096
R01 · FY2024 · MH · contact PI
Neural and cognitive consequences of COVID-19 survival.$0
I01 · FY2024 · VA
Plasma neuronal-derived exosomes are biomarkers of HIV cognitive impairment$589,414
R01 · FY2023 · MH · contact PI
ShEEP Request for Particle Matrix ZetaView$0
IS1 · FY2023 · VA · contact PI
Neural and cognitive consequences of COVID-19 survival.$0
I01 · FY2023 · VA
Plasma neuronal-derived exosomes are biomarkers of HIV cognitive impairment$638,277
R01 · FY2022 · MH · contact PI
Neural and cognitive consequences of COVID-19 survival.$0
I01 · FY2022 · VA
Plasma neuronal-derived exosomes are biomarkers of HIV cognitive impairment$647,935
R01 · FY2021 · MH · contact PI
Plasma neuronal-derived exosomes are biomarkers of HIV cognitive impairment$543,233
R01 · FY2020 · MH · contact PI
Engineered exosomes target inflammation in HIV$192,612
R21 · FY2019 · AI · contact PI
Engineered exosomes target inflammation in HIV$244,533
R21 · FY2018 · AI · contact PI
Brain-derived exosomes as blood markers of HIV cognitive impairment$191,625
R21 · FY2018 · MH · contact PI
Hepatitis C Drives Neuropathogenesis in HIV/HCV Coinfection Patients$486,540
R01 · FY2017 · MH · contact PI
Brain-derived exosomes as blood markers of HIV cognitive impairment$229,950
R21 · FY2017 · MH · contact PI
Hepatitis C Drives Neuropathogenesis in HIV/HCV Coinfection Patients$508,271
R01 · FY2016 · MH · contact PI
Exosomes from HIV-activated monocytes induce endothelial cell activation$191,625
R21 · FY2016 · HL · contact PI
Hepatitis C Drives Neuropathogenesis in HIV/HCV Coinfection Patients$508,271
R01 · FY2015 · MH · contact PI
Interferon-a drives peripheral activation and brain injury in chronic HIV$342,000
R01 · FY2015 · MH · contact PI
Exosomes from HIV-activated monocytes induce endothelial cell activation$229,950
R21 · FY2015 · HL · contact PI
Hepatitis C Drives Neuropathogenesis in HIV/HCV Coinfection Patients$508,271
R01 · FY2014 · MH · contact PI
Interferon-a drives peripheral activation and brain injury in chronic HIV$342,000
R01 · FY2014 · MH · contact PI
Hepatitis C Drives Neuropathogenesis in HIV/HCV Coinfection Patients$508,271
R01 · FY2013 · MH · contact PI
Interferon-a drives peripheral activation and brain injury in chronic HIV$328,320
R01 · FY2013 · MH · contact PI
Interferon-a drives peripheral activation and brain injury in chronic HIV$342,000
R01 · FY2012 · MH · contact PI
Hepatitis C Drives Neuropathogenesis in HIV/HCV Coinfection Patients$345,263
R01 · FY2011 · MH · contact PI
Role of PreS2 Mutants in Pathogenesis of Chronic Hepatitis B$272,098
R01 · FY2011 · CA · contact PI
Hepatitis C Drives Neuropathogenesis in HIV/HCV Coinfection Patients$348,750
R01 · FY2010 · MH · contact PI
Role of PreS2 Mutants in Pathogenesis of Chronic Hepatitis B$280,514
R01 · FY2010 · CA · contact PI
Role of PreS2 Mutants in Pathogenesis of Chronic Hepatitis B$840,347
R01 · FY2009 · CA · contact PI
Hepatitis C Drives Neuropathogenesis in HIV/HCV Coinfection Patients$348,750
R01 · FY2009 · MH · contact PI
Role of PreS2 Mutants in Pathogenesis of Chronic Hepatitis B$280,514
R01 · FY2009 · CA · contact PI
Predicting HAD using Monocyte Profiling and Neuroimaging$391,124
R01 · FY2008 · MH · contact PI
Predicting HAD using Monocyte Profiling and Neuroimaging$391,124
R01 · FY2007 · MH · contact PI
HIV-1 Infection Increases Brain Amyloid Beta$402,806
R01 · FY2006 · MH · contact PI
Predicting HAD using Monocyte Profiling and Neuroimaging$402,806
R01 · FY2006 · MH · contact PI
Predicting HAD using Monocyte Profiling and Neuroimaging$412,500
R01 · FY2005 · MH
HIV-1 Infection Increases Brain Amyloid Beta$412,500
R01 · FY2005 · MH
Role of Inflammation in HIV Dementia$123,750
R21 · FY2005 · MH
HIV-1 Infection Increases Brain Amyloid Beta$412,500
R01 · FY2004 · MH
Role of Inflammation in HIV Dementia$165,000
R21 · FY2004 · MH
HIV-1 Infection Increases Brain Amyloid Beta$378,750
R01 · FY2003 · MH
Role of Inflammation in HIV Dementia$303,000
R21 · FY2003 · MH
MONOCYTE SUBSETS AND AIDS DEMENTIA$388,086
R01 · FY2001 · MH
MONOCYTE SUBSETS AND AIDS DEMENTIA$379,689
R01 · FY2000 · MH